Abstract
Objective: Aspiration pneumonia (AP) and primary lung abscess (PLA) are rare diseases, which can be associated with life-threatening complications. The main cause of these diseases is an aspiration of infectious material from the oral cavaty or stomach. There is limited information on optimal antibacterial therapeutic regimens, which schould include anaerobic bacteria. We compared clinical and bacteriologic efficacy and safety of moxifloxacin (MOX) with that of ampicillin/sulbactam (AMP/SBT) in the treatment of AP and PLA.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
